DE20214753U1 - Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention einer Lichtdermatose - Google Patents
Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention einer LichtdermatoseInfo
- Publication number
- DE20214753U1 DE20214753U1 DE20214753U DE20214753U DE20214753U1 DE 20214753 U1 DE20214753 U1 DE 20214753U1 DE 20214753 U DE20214753 U DE 20214753U DE 20214753 U DE20214753 U DE 20214753U DE 20214753 U1 DE20214753 U1 DE 20214753U1
- Authority
- DE
- Germany
- Prior art keywords
- weight
- parts
- pharmaceutical composition
- composition according
- approx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims 16
- 230000002265 prevention Effects 0.000 title 1
- 239000003814 drug Substances 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- 108010076525 DNA Repair Enzymes Proteins 0.000 claims 4
- 102000011724 DNA Repair Enzymes Human genes 0.000 claims 4
- 230000005778 DNA damage Effects 0.000 claims 4
- 231100000277 DNA damage Toxicity 0.000 claims 4
- 206010048768 Dermatosis Diseases 0.000 claims 4
- 208000017520 skin disease Diseases 0.000 claims 4
- 241000219357 Cactaceae Species 0.000 claims 3
- 108010046331 Deoxyribodipyrimidine photo-lyase Proteins 0.000 claims 3
- 102000004099 Deoxyribonuclease (Pyrimidine Dimer) Human genes 0.000 claims 3
- 108010082610 Deoxyribonuclease (Pyrimidine Dimer) Proteins 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 3
- 240000008607 Opuntia megacantha Species 0.000 claims 3
- 241000192589 Synechococcus elongatus PCC 7942 Species 0.000 claims 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims 2
- 240000008397 Ganoderma lucidum Species 0.000 claims 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims 2
- 241000191938 Micrococcus luteus Species 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 2
- 239000012876 carrier material Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims 1
- 108010034927 3-methyladenine-DNA glycosylase Proteins 0.000 claims 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims 1
- 235000004866 D-panthenol Nutrition 0.000 claims 1
- 239000011703 D-panthenol Substances 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 241000208690 Hamamelis Species 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 244000042664 Matricaria chamomilla Species 0.000 claims 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims 1
- 241000192041 Micrococcus Species 0.000 claims 1
- 206010041303 Solar dermatitis Diseases 0.000 claims 1
- 206010042496 Sunburn Diseases 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 229960000458 allantoin Drugs 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims 1
- 229940036350 bisabolol Drugs 0.000 claims 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 230000007850 degeneration Effects 0.000 claims 1
- 229960003949 dexpanthenol Drugs 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 1
- 235000020688 green tea extract Nutrition 0.000 claims 1
- 229940094952 green tea extract Drugs 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 239000002088 nanocapsule Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 229940101267 panthenol Drugs 0.000 claims 1
- 235000020957 pantothenol Nutrition 0.000 claims 1
- 239000011619 pantothenol Substances 0.000 claims 1
- 230000002028 premature Effects 0.000 claims 1
- 230000009759 skin aging Effects 0.000 claims 1
- 229940046009 vitamin E Drugs 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Description
Claims (15)
ca. 1-40 Gewichtsteile, vorzugsweise ca. 2-25 Gewichtsteile, insbesondere ca. 2-15 Gewichtsteile des Bestandteils (i) und
ca. 1-40 Gewichtsteile, vorzugsweise ca. 2-25 Gewichtsteile, insbesondere ca. 2-15 Gewichtsteile des Bestandteils (ii),
und als restlichen Bestandteil (v) einen oder mehrere Zusatzstoffe,
bezogen auf 100 Gewichtsteile einer Zusammensetzung mit den Bestandteilen (i), (ii) und (v), enthält.
ca. 1-25 Gewichtsteile, vorzugsweise ca. 2-20 Gewichtsteile, insbesondere ca. 2-15 Gewichtsteile des Bestandteils (i),
ca. 1-30 Gewichtsteile, vorzugsweise ca. 2-25 Gewichtsteile, insbesondere ca. 2-15 Gewichtsteile des Bestandteils (ii),
sowie als Bestandteil (iii) ca. 20-40 Gewichtsteile, vorzugsweise ca. 25-35 Gewichtsteile Glycerin,
und als restlichen Bestandteil (v) einen oder mehrere Zusatzstoffe,
bezogen auf 100 Gewichtsteile einer Zusammensetzung mit den Bestandteilen (i), (ii), (iii) und (v), enthält.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE20214753U DE20214753U1 (de) | 2002-09-24 | 2002-09-24 | Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention einer Lichtdermatose |
US10/431,624 US20040057917A1 (en) | 2002-09-24 | 2003-05-07 | Pharmaceutical composition for treatment and /or prevention of a light-dermatosis |
AU2003204239A AU2003204239B2 (en) | 2002-09-24 | 2003-05-13 | Pharmaceutical composition for treatment and/or prevention of a light-dematosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE20214753U DE20214753U1 (de) | 2002-09-24 | 2002-09-24 | Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention einer Lichtdermatose |
Publications (1)
Publication Number | Publication Date |
---|---|
DE20214753U1 true DE20214753U1 (de) | 2002-12-12 |
Family
ID=7975395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE20214753U Expired - Lifetime DE20214753U1 (de) | 2002-09-24 | 2002-09-24 | Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention einer Lichtdermatose |
Country Status (3)
Country | Link |
---|---|
US (1) | US20040057917A1 (de) |
AU (1) | AU2003204239B2 (de) |
DE (1) | DE20214753U1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034891A2 (en) * | 2003-10-10 | 2005-04-21 | Access Business Group International Llc. | Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme |
US7758878B2 (en) | 2003-10-10 | 2010-07-20 | Access Business Group International Llc | Cosmetic treatment system and methods |
CN104784466A (zh) * | 2015-04-21 | 2015-07-22 | 上海卡卡化妆品有限公司 | 具有舒敏抗刺激功效的外用中药组合物及其制备方法 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776368B2 (en) * | 2003-08-13 | 2010-08-17 | Smarthealth, Inc. | Gloves containing dry powdered aloe and method of manufacturing |
US20050186231A1 (en) * | 2004-02-19 | 2005-08-25 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Stabilization with substituted ureas against color degradation of personal care products |
WO2006018198A1 (de) * | 2004-08-13 | 2006-02-23 | Henkel Kommanditgesellschaft Auf Aktien | Kosmetische und dermatologische zusammensetzungen mit (2-hydroxyethyl)harnstoff |
NZ539076A (en) * | 2005-03-29 | 2008-05-30 | Blis Technologies Ltd | Skin treatment compositions |
US8193155B2 (en) * | 2009-02-09 | 2012-06-05 | Elc Management, Llc | Method and compositions for treating skin |
US8703161B2 (en) * | 2007-08-13 | 2014-04-22 | Elc Management, Llc | Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators |
US20090047309A1 (en) * | 2007-08-13 | 2009-02-19 | Maes Daniel H | Cosmetic methods and compositions for repairing human skin |
CA2700335C (en) * | 2007-09-21 | 2015-12-01 | Pharmabrand S.A. | Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser |
US20090324705A1 (en) * | 2008-02-13 | 2009-12-31 | Nina Vikhrieva | Phytonutrient compositions for topical use |
CA2834765A1 (en) | 2011-04-29 | 2012-11-01 | Photomedex, Inc. | Topical dna repair compositions |
ES2393338B1 (es) * | 2011-06-09 | 2013-08-19 | Isdin, S. A. | Uso de fotoliasa para la reducción o mejora del campo de cancerización subclínico asociado a la queratosis actínica. |
EP2869810B1 (de) * | 2012-07-05 | 2018-03-07 | Biodue S.p.A. | Zusammensetzungen zur vorbeugung und reparatur von haut- und augenschäden durch uv-strahlung |
US20140017182A1 (en) * | 2012-07-12 | 2014-01-16 | Precision Dermatology, Inc. | Topical Formulations Comprising DNA Repair Enzymes, and Methods of Use Thereof |
US10383815B2 (en) | 2012-09-14 | 2019-08-20 | Elc Management Llc | Method and compositions for improving selective catabolysis in cells of keratin surfaces |
TWM467462U (zh) * | 2013-06-05 | 2013-12-11 | Chin-Tung Lee | 幾丁質修飾乙醇微脂載體結構 |
CA3026108A1 (en) | 2016-06-10 | 2017-12-14 | Clarity Cosmetics Inc. | Non-comedogenic hair and scalp care formulations and method for use |
AU2019391274A1 (en) * | 2018-12-05 | 2021-01-07 | Illumina Cambridge Limited | Methods and compositions for cluster generation by bridge amplification |
WO2020126602A1 (en) | 2018-12-18 | 2020-06-25 | Illumina Cambridge Limited | Methods and compositions for paired end sequencing using a single surface primer |
CN111494391B (zh) * | 2020-06-17 | 2023-03-17 | 西南大学 | 黄杨碱在制备自噬诱导剂中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU83173A1 (fr) * | 1981-02-27 | 1981-06-05 | Oreal | Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion |
US5824312A (en) * | 1994-03-10 | 1998-10-20 | Imarx Pharmaceutical Corp. | Sunscreen agents from natural sources |
US6159487A (en) * | 1998-03-24 | 2000-12-12 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Moistened cosmetic eye treatment fads |
US6238672B1 (en) * | 1999-04-23 | 2001-05-29 | E. Excel International Inc. | Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice |
US6352685B2 (en) * | 1999-12-24 | 2002-03-05 | KOSé CORPORATION | External preparation for skin |
US6447820B1 (en) * | 2001-01-22 | 2002-09-10 | Sarfaraz K Niazi | Pharmaceutical composition for the prevention and treatment of scar tissue |
US6555118B1 (en) * | 2001-02-22 | 2003-04-29 | Sarfaraz K Niazi | Pharmaceutical preparation for the treatment of topical wounds and ulcers |
US6623745B2 (en) * | 2001-02-27 | 2003-09-23 | Tbh Marks, Inc. | Emollient |
-
2002
- 2002-09-24 DE DE20214753U patent/DE20214753U1/de not_active Expired - Lifetime
-
2003
- 2003-05-07 US US10/431,624 patent/US20040057917A1/en not_active Abandoned
- 2003-05-13 AU AU2003204239A patent/AU2003204239B2/en not_active Expired
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005034891A2 (en) * | 2003-10-10 | 2005-04-21 | Access Business Group International Llc. | Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme |
WO2005034891A3 (en) * | 2003-10-10 | 2005-05-19 | Access Business Group Int Llc | Composition comprising a rosmarinus officinalis plant extract, a centella, echinacea or alpinia plant extract and a dna repair enzyme |
US7758878B2 (en) | 2003-10-10 | 2010-07-20 | Access Business Group International Llc | Cosmetic treatment system and methods |
US7959953B2 (en) | 2003-10-10 | 2011-06-14 | Access Business Group International Llc | Cosmetic composition and methods |
CN104784466A (zh) * | 2015-04-21 | 2015-07-22 | 上海卡卡化妆品有限公司 | 具有舒敏抗刺激功效的外用中药组合物及其制备方法 |
CN104784466B (zh) * | 2015-04-21 | 2018-04-03 | 上海中翊日化有限公司 | 具有舒敏抗刺激功效的外用中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US20040057917A1 (en) | 2004-03-25 |
AU2003204239A1 (en) | 2004-04-08 |
AU2003204239B2 (en) | 2009-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE20214753U1 (de) | Pharmazeutische Zusammensetzung zur Behandlung und/oder Prävention einer Lichtdermatose | |
DE60014180T2 (de) | Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion | |
DE202012012873U1 (de) | Topische Hautpflegeformulierungen, die Pflanzenextrakte umfassen | |
JP2001322943A (ja) | ニキビ予防治療剤 | |
CN103027867A (zh) | 晒后卸妆修复湿巾整理液 | |
CN108379168A (zh) | 一种植物修复角质层的化妆品及其制备方法 | |
US8636988B2 (en) | Composition for treatment of sunburned skin | |
DE202012013021U1 (de) | Hautpflegeformulierung | |
CN109010115A (zh) | 一种具有抗炎功效的舒敏乳霜 | |
DE60115202T2 (de) | Kosmetisches schlankheitsmittel enthaltend einen pflanzenextrakt mit einem natruretischem peptid | |
WO2008119097A1 (de) | Pharmazeutisches mittel gegen juckreiz und schmerz | |
CN107440920B (zh) | 一种深层螯合美容洁面面膜及制备方法 | |
DE202007008601U1 (de) | Mittel zur Behandlung von Haaren sowie Verwendung des Mittels | |
DE19718848C2 (de) | Mittel zur Behandlung von Cellulitis | |
DE102010044674B9 (de) | Perkutanes Applikationssystem | |
CN107648151A (zh) | 一种珍珠防晒胶囊及其制备方法 | |
EP1342468B1 (de) | Neue kosmetische Rohstoffe aus der Pflanzenfamilie Zosteraceae für spezielle kosmetische Wirkungen und Anwendungen | |
CN107625686A (zh) | 紧致粉 | |
CN106137878B (zh) | 一种淘米水调理组合物及其制备方法和应用 | |
DE102006054653A1 (de) | Körper- oder Schönheitspflegemittel | |
CN109125239A (zh) | 一种复方中药美白护肤霜及制备方法 | |
CN108245603A (zh) | 损伤酒 | |
KR20070008150A (ko) | 석류 추출물, 토마토 추출물 및 포도발효 추출물을유효성분으로 포함하는 조성물 및 이의 용도 | |
WO2017197535A1 (de) | Erzeugnis zum therapieren und vorbeugen von burnout-syndromen der kopfhaut und der haut | |
KR20100094109A (ko) | 대추가 함유된 기능성 스킨로션 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R207 | Utility model specification |
Effective date: 20030123 |
|
R081 | Change of applicant/patentee |
Owner name: KWIZDA PHARMA GMBH, AT Free format text: FORMER OWNER: HANDO HANDELS GES. M.B.H., GRAZ, AT Effective date: 20031203 |
|
R079 | Amendment of ipc main class |
Free format text: PREVIOUS MAIN CLASS: A61K0035780000 Ipc: A61K0036330000 |
|
R150 | Utility model maintained after payment of first maintenance fee after three years |
Effective date: 20051130 |
|
R081 | Change of applicant/patentee |
Owner name: KWIZDA PHARMA GMBH, AT Free format text: FORMER OWNER: KARL HEINZ DOLINSCHEK,PETER WOLF, , AT Effective date: 20080130 |
|
R151 | Utility model maintained after payment of second maintenance fee after six years |
Effective date: 20081013 |
|
R081 | Change of applicant/patentee |
Owner name: KWIZDA PHARMA GMBH, AT Free format text: FORMER OWNER: PHARMATRADE LTD., CLAYMONT, US Effective date: 20090416 |
|
R152 | Utility model maintained after payment of third maintenance fee after eight years |
Effective date: 20101019 |
|
R071 | Expiry of right | ||
R071 | Expiry of right |